Larvol Delta - SIERRA-Durvalumab-and-Tremelimumab-as-First-Line-Treatment-in-Participants-With-Advanced-Hepatocellular-Carcinoma-HCC

Imfinzi (durvalumab) - AstraZeneca

Imjudo (tremelimumab-actl) - AstraZeneca

http://clinicaltrials.gov/ct2/show/NCT05883644

Sep 15, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next